What is Harmony Biosciences Holdings Receivables Turnover?
The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Harmony Biosciences Holdings's Revenue for the
three
months ended in Sep. 2024 was $186.0 Mil. Harmony Biosciences Holdings's average Accounts Receivable for the
three
months ended in Sep. 2024 was $82.3 Mil.
Hence, Harmony Biosciences Holdings's Receivables Turnover for the
three
months ended in Sep. 2024 was 2.26.
Harmony Biosciences Holdings Receivables Turnover Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Harmony Biosciences Holdings's Receivables Turnover
For the Biotechnology subindustry, Harmony Biosciences Holdings's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Harmony Biosciences Holdings's Receivables Turnover Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Harmony Biosciences Holdings's Receivables Turnover distribution charts can be found below:
* The bar in red indicates where Harmony Biosciences Holdings's Receivables Turnover falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.
Harmony Biosciences Holdings Receivables Turnover Related Terms
Thank you for viewing the detailed overview of Harmony Biosciences Holdings's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HRMY has been successfully added to your 